Technical Analysis for ERYP - Erytech Pharma S.A.

Grade Last Price % Change Price Change
grade F 7.07 -3.42% -0.25
ERYP closed down 3.42 percent on Friday, May 24, 2019, on 33 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ERYP trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -3.42%
Outside Day Range Expansion -3.42%
Oversold Stochastic Weakness -3.42%
Narrow Range Bar Range Contraction -0.42%
Doji - Bullish? Reversal -0.42%
Stochastic Reached Oversold Weakness -0.42%
Gapped Down Weakness -0.42%

Older signals for ERYP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.
Medicine Biopharmaceutical Cancer Clinical Medicine Antineoplastic Drugs Leukemia Acute Lymphoblastic Leukemia Asparaginase Medicinal Products
Is ERYP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.62
52 Week Low 5.45
Average Volume 3,074
200-Day Moving Average 9.1688
50-Day Moving Average 7.9297
20-Day Moving Average 7.5045
10-Day Moving Average 7.268
Average True Range 0.3127
ADX 23.65
+DI 24.3106
-DI 38.3587
Chandelier Exit (Long, 3 ATRs ) 7.3719
Chandelier Exit (Short, 3 ATRs ) 8.0081
Upper Bollinger Band 8.1178
Lower Bollinger Band 6.8912
Percent B (%b) 0.15
BandWidth 16.34486
MACD Line -0.1876
MACD Signal Line -0.1719
MACD Histogram -0.0157
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.40
Resistance 3 (R3) 7.44 7.36 7.35
Resistance 2 (R2) 7.36 7.28 7.35 7.33
Resistance 1 (R1) 7.22 7.23 7.18 7.18 7.31
Pivot Point 7.14 7.14 7.13 7.13 7.14
Support 1 (S1) 7.00 7.06 6.96 6.96 6.83
Support 2 (S2) 6.92 7.01 6.91 6.81
Support 3 (S3) 6.78 6.92 6.80
Support 4 (S4) 6.74